HANNAH.BO · BSE
Hannah Joseph Hospital Limited
₹110.85
-0.14% (-₹0.15)
Prev. close
₹111
Volume
30,000
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Hannah Joseph Hospital Limited
Hannah Joseph Hospital Limited operates a hospital under the name of Hannah Joseph Hospital. It offers health services, such as neuroscience, cardiac sciences, trauma care, and psychiatry; and medical services, including Cath lab, in-house laboratory, Doppler scan, CT scan, X-ray, and MRI, as well as operating theaters, ICUs, and CCUs. The company was founded in 2008 and is headquartered in Madurai, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Dr. Moses Joseph Arunkumar
Headquarters
Madurai
Employees
292
Website
hannahjosephhospital.comExchange
View on BSE ↗Key stats
Market cap
₹251.61 Cr
P/E ratio (TTM)
17.5
Dividend yield
1.80%
EPS (TTM)
₹6.32
Shares float
55.30 L
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: Yahoo (no NSE corporate-actions ledger for this listing).
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹54.63 Cr | ₹63.41 Cr | ₹77.53 Cr | ₹92.05 Cr | |
| EBITDA | — | ₹16.14 Cr | ₹17.78 Cr | ₹20.89 Cr | ₹25.70 Cr |
| — | ₹1.01 Cr | ₹4.07 Cr | ₹7.21 Cr | ₹11.18 Cr | |
| Diluted EPS | ₹0.15 | ₹0.45 | ₹1.79 | ₹3.18 | ₹6.32 |
Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹92.14 Cr | ₹89.97 Cr | ₹96.63 Cr | ₹133.11 Cr | |
| ₹48.85 Cr | ₹36.03 Cr | ₹36.86 Cr | ₹26.90 Cr | |
| Stockholders' equity | ₹34.55 Cr | ₹45.71 Cr | ₹51.94 Cr | ₹97.37 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹20.81 Cr | ₹8.04 Cr | ₹19.41 Cr | ₹20.68 Cr | |
| Investing cash flow | ₹-4.96 Cr | ₹-3.60 Cr | ₹-13.58 Cr | ₹-14.08 Cr |
| ₹-10.43 Cr | ₹-2.62 Cr | ₹-2.90 Cr | ₹24.95 Cr | |
| Capital expenditure | ₹-3.79 Cr | ₹-2.34 Cr | ₹-12.13 Cr | ₹-14.65 Cr |
| End cash position | ₹3.86 Cr | ₹4.68 Cr | ₹11.62 Cr | ₹8.27 Cr |
Debt issued, Debt repaid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| Hannah Joseph Hospital Limited | ₹251.95 Cr | ₹111 | 17.6 | 2.59 | 11.5% | 0.28 | +18.7% | — |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
1 index
Weight is BSE’s own published index weight. Indices without weight data are listed without one, in alphabetical order after the weighted ones.